Cited by 8Traditional Chinese Medicine StudiesComplementary and Alternative Medicine StudiesHistory of Medicine Studies

The DOI matches its Crossref record, with a small difference in title or year; 19 of the 23 references it cites were found in a registry or an index; 4 of the 24 sources its claims cite were checked for support.

Politics of Knowledge in the Debates on Toxicity in Ayurvedic Medicines

Open access
Banerjee, Madhulika·2013·Asian Medicine

Abstract

<section class="abstract">In the last decade, a controversy has arisen over a specific type of herbo-mineral ayurvedic preparations called bhasmas (Skt. bhasman). The controversy mainly concerned serious complications or even the death of patients after having taken these medicines. Since these medicines were metal-based preparations, and specifically included lead or mercury, their toxicity was interpreted as causing the patients’ suffering. In response to that, in public discourse a plethora of writing on the issue of toxicity in ayurvedic medicines ensued, both accusatory and defensive in tone. This laid out the potential for their condemnation, with serious implications for their credibility, not to speak of their markets. This article attempts to analyse this writing, focusing mainly on the academic publications, from the perspective of the politics of knowledge. It will argue that hierarchies in the epistemologies of medical knowledge systems guide the scientific analysis of these herbo-mineral preparations, some of which contain mercury, illustrating how this happens through publications that are unequivocally critical of bhasmas, those that are defensive of them, and those that indicate a median position. It will also analyse the possible regulatory and manufacturing regimes that can emerge when a certain kind of balanced analysis informs policy-making. Focusing on the modes of translation between epistemologies of different knowledge systems that have characterised the process of making ‘traditional’ knowledge contemporary, it shows how this principally reflects the hierarchy between dominant and marginal knowledge on an everyday basis, affecting most production and marketing decisions, that backfire not only on specific products, but affect an evaluation of the system as a whole. </section>

Overview

Integrity signals

Registry

Crossref · 10.1163/15734218-12341288

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

61 Own interpretation · 12 Sources not found · 7 No full text of the sources · 6 Own result · 3 No basis given · 2 Supported · 2 Partly supported · 1 Not checked yet · accuracy not yet measured

Show all 26 claims

  • Probably not a substantial claim. 57
  • It may state two separate claims as one. 36
68 of 68
  • The paper relies on this without support.

    Herbo-mineral products are a very small proportion of the ayurvedic medicines manufactured and used in India.

    “although a high proportion of India's population uses Ayurveda, herbo-mineral products are a very small proportion of the medicines manufactured in the first place.Thus, these are a small proportion of ayurvedic medicines that people use.”
  • The paper relies on this without support.

    Jambrulin is a legally-recognised proprietary ayurvedic medicine, different from a classical formulation.

    “Second, the name Jambrulin indicates a legally-recognised category of ayurvedic medicine known as 'proprietary' medicine, which is different from a 'classical' formulation.”
  • The paper relies on this without support.

    The articles indicating non-toxicity of bhasmas are part of a large body of literature generated in India over the last 60 to 70 years.

    “The articles indicating the non-toxicity of bhasmas are part of a large body of literature that has been generated in the last 60 to 70 years in India.”
  • The paper relies on this without support.

    Very little of the Indian literature on the non-toxicity of bhasmas is cited in international publications on Ayurveda.

    “Yet, very little of this literature is cited in international publications on Ayurveda.”
  • The paper relies on this without support.

    Ayurvedic medicines may be marketed in India as classical and as patent or proprietary formulations according to law.

    “Ayurvedic medicines, according to the law in India, may be marketed in two forms, as 'classical' formulations and as 'patent' or 'proprietary' formulations.”
5 of 5

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 23 references

Research works printed but not linked: 9

  1. Banerjee, 2009, Power, Knowledge, Medicine
  2. Bode, 2008, Taking Traditional Knowledge to the Market: The Modern Image of the Ayurvedic and Unani Industry 1980–2000
  3. Dahanukar, 1982, ‘Influence of Trikatu on Rifampicin Bioavailability’, Indian Drugs, 19, 271
  4. 1962, Ayurvedic Pharmacopoeia of India
  5. Obringer, 1997, L’Aconit et L’Orpiment. Drogues et Poisons en Chine Ancienne et Médiévale
  6. Patwardhan, 2005, ‘Heavy Metals and Ayurveda’, Current Science, 88, 1535
  7. Priya, 2011, Status and Role of AYUSH and Local Health Traditions under the National Rural Health Mission: Report of a Study of the National Health Systems Resource Centre, Ministry of Health and Family Welfare, New Delhi
  8. Sharma, 2004, Rastarangini
  9. Singh, 2008, ‘Toxic Metal Analysis in Ayurvedic Drug Systems’, Conference Report: 23rd National Systems Conference NSC 2008, December 17–19, 664

Cited by

Sorted by citations

See all 8

Metadata

Authors
Banerjee, M.
Affiliations
University of Delhi (IN)
Corresponding author
Banerjee, Madhulika
Venue
Asian Medicine
Published
2013-09-17
Volume
8
Issue
1
Pages
153-179
ISSN
  • 1573-420X (ISSN-L)
  • 1573-4218
OpenAlex
W94281210
Cited by
8
References
23
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 1 · 2015: 1 · 2014: 1
FWCI
1.77
Type
journal article
Language
en
Open access
Locations
Asian Medicine (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Social Sciences › Arts and Humanities › History › History of Medicine Studies
Keywords
politics of knowledge, Ayurveda, Bhasma, herbo-mineral preparations, toxicity, mercury, lead, epistemological hierarchy, knowledge translation, traditional knowledge, regulatory policy, drug regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Politics of Knowledge in the Debates on Toxicity in Ayurvedic Medicines. https://app.cochat.ai/papers/10.1163/15734218-12341288
The paper
Banerjee, M. (2013). Politics of Knowledge in the Debates on Toxicity in Ayurvedic Medicines. Asian Medicine. https://doi.org/10.1163/15734218-12341288